Dr Gareth Morgan is professor of medicine and pathology and director of the Myeloma Institute for Research and Therapy at the University of Arkansas for Medical Sciences (UAMS), one of the world’s foremost myeloma treatment centres. Previously he was professor of hematology and director of the Centre for Myeloma Research at The Royal Marsden Institute NHS Foundation Trust and the Institute of Cancer Research in London, the largest comprehensive cancer institute in Europe. Dr Morgan was previously a director of Myeloma UK as well as a member of the Scientific Board of the International Myeloma Foundation. He is the founding director of the European Myeloma Network.
Dr Morgan is an internationally recognized scientist and clinician in the field of the molecular genetics in blood cell cancers. In addition to his clinical role, Dr Morgan also is engaged in advanced research in molecular diagnostics, drug development and clinical trials and has authored more than 450 articles appearing in leading peer-reviewed journals, New England Journal of Medicine, Blood, Journal of Clinical Oncology, Leukemia, Lancet-Oncology, and Clinical Cancer Research.
Dr. Morgan received his doctorate on the genetics of leukemia from the University of London in 1991 and his MD in 1981 from the Welsh National School of Medicine.